Teva Pharmaceutical Industries's revenue 2018-2021 by region

Published by
Matej Mikulic,
Feb 10, 2022
This statistic shows the revenues of pharmaceutical company Teva from 2018 to 2021, sorted by region. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2021, the company's revenues in Europe came to approximately 4.9 billion U.S. dollars.

Revenue of Teva Pharmaceutical Industries from 2018 to 2021, by region (in million U.S. dollars)

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Teva "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Teva

Market overview

5

Key numbers

5

Regions and segments

3

Costs and expenses

3

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in the PhilippinesInsurance industry in the PhilippinesDemographics of the PhilippinesCoronavirus (COVID-19) pandemic in the PhilippinesHealth care industry in the Philippines
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu